Data as of Nov 21
| +0.04 / +3.08%|
The 1 analysts offering 12-month price forecasts for Biostar Pharmaceuticals Inc have a median target of 21.00, with a high estimate of 21.00 and a low estimate of 21.00. The median estimate represents a +1,467.16% increase from the last price of 1.34.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.